《新股消息》天津建發(02515.HK)未能釐定發售價叫停上市
原定於下周二(16日)掛牌的天津建發(02515.HK)宣布,在目前市況下與整體協調人未能在規定的時間內釐定發售價及簽立定價協議,香港包銷協議隨即終止,全球發售計劃將推遲,並且不會按照招股章程所載時間表進行,相關首次公開發售申請股款將退還予申請人。
天津建發強調,推遲全球發售的決定不影響當前業務,致力於發展壯大其業務,會盡快完成全球發售及上市。
天津建發為天津工程施工服務商,是次上市擬全球發售5,395萬股H股,每股招股價介乎2.5至2.9元,以招股價中位數2.7元計,原訂上市料淨集資約1.08億元,獨家保薦人光大證券國際。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.